Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
26.54
-0.86 (-3.14%)
At close: May 1, 2024, 4:00 PM
27.06
+0.52 (1.96%)
After-hours: May 1, 2024, 4:53 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $316.61 million as of May 1, 2024. Its market cap has increased by 454.48% in one year.
Market Cap
316.61M
Enterprise Value
227.64M
1-Year Change
454.48%
Ranking
Category
Stock Price
$26.54
Market Cap Chart
Since March 28, 2018, Q32 Bio's market cap has decreased from $673.30M to $316.61M, a decrease of -52.98%. That is a compound annual growth rate of -11.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 88.50M | -5.65% |
Apr 29, 2024 | 93.80M | 3.65% |
Apr 26, 2024 | 90.50M | -0.77% |
Apr 25, 2024 | 91.20M | 6.17% |
Apr 24, 2024 | 85.90M | 4.25% |
Apr 23, 2024 | 82.40M | 2.74% |
Apr 22, 2024 | 80.20M | 10.47% |
Apr 19, 2024 | 72.60M | -7.75% |
Apr 18, 2024 | 78.70M | 1.03% |
Apr 17, 2024 | 77.90M | -3.47% |
Apr 16, 2024 | 80.70M | -5.50% |
Apr 15, 2024 | 85.40M | -8.47% |
Apr 12, 2024 | 93.30M | 21.33% |
Apr 11, 2024 | 76.90M | 10.81% |
Apr 10, 2024 | 69.40M | 0.87% |
Apr 9, 2024 | 68.80M | -0.58% |
Apr 8, 2024 | 69.20M | 5.97% |
Apr 5, 2024 | 65.30M | -2.39% |
Apr 4, 2024 | 66.90M | -2.76% |
Apr 3, 2024 | 68.80M | -3.10% |
Apr 2, 2024 | 71.00M | 22.20% |
Apr 1, 2024 | 58.10M | 5.64% |
Mar 28, 2024 | 55.00M | 5.36% |
Mar 27, 2024 | 52.20M | -2.97% |
Mar 26, 2024 | 53.80M | -0.92% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sera Prognostics | 363.13M |
Amarin Corporation | 358.54M |
Ocugen | 357.68M |
Tenaya Therapeutics | 356.46M |
Precigen | 348.49M |
FibroBiologics | 345.19M |
Caribou Biosciences | 341.39M |
Esperion Therapeutics | 339.13M |